-
Innovation Ranking
NewInnovation Ranking – Toyo Ink SC Holdings Co Ltd
Toyo Ink SC Holdings Co Ltd (Toyo Ink) is a chemical manufacturer and distributor. The company provides services such as printing and information business, a packaging business, polymer and coating business, color and functional materials business and others. Toyo Ink’s product portfolio includes printing inks, industrial chemicals, offset inks, inkjet inks, gravure inks, gravure solvents, screen inks, flexographic inks, can coatings, adhesives, pigments, high function pigments and plastic colorants, and printing equipment, and systems. The company has operations in France,...
-
Sector Analysis
NewInternet of Things (IoT) Market Trends and Analysis by End-User, Product, Enterprise Size, Vertical, Region, and Segment Forecast to 2027
Accessing the in-depth insights from the ‘Internet of Things’ report can help: Gain a valuable understanding of the current and future state of the market. This will allow businesses to make informed decisions about market entry, product development, and investments Identify competitors' capabilities to stay ahead in the market Identify segments and get an understanding of various stakeholders across different stages of the entire value chain Anticipate changes in demand and adjust the business development strategies Identify potential regions and countries for growth opportunities How...
-
Sector Analysis
NewEdge Computing Market Size, Trends and Analysis by IT Infrastructure, Vertical, Employee Size Band, Region and Segment Forecast to 2027
Accessing the in-depth insights from the ‘Edge Computing’ report can help: Understand the current and future state of the market, allowing businesses to make informed decisions about market entry, product development, and Identify competitors' capabilities to stay ahead in the market. Identify segments and know the stakeholders across different stages of the value Anticipate changes in demand and adjust the business development strategies Identify potential regions and countries for growth How is our ‘Edge Computing’ report different from other reports...
-
Product Insights
Image Guided Surgery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Image Guided Surgery Pipeline Market Report Overview Image Guided Surgery devices use real-time images during surgery to assist surgeons in precisely guiding the surgical instruments to the anatomic structures. It helps minimize the chances of errors and reduce the procedure time. The Image Guided Surgery pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lurbinectedin in Neuroendocrine Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lurbinectedin in Neuroendocrine Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lurbinectedin in Neuroendocrine Carcinoma Drug Details: Lurbinectedin (Zepzelca) is a synthetic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Gevokizumab in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Gevokizumab in Metastatic Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gevokizumab in Metastatic Colorectal Cancer Drug Details: Gevokizumab (XOMA-052) is developing...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Trastuzumab in Ductal Carcinoma In Situ
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trastuzumab in Ductal Carcinoma In Situ report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trastuzumab in Ductal Carcinoma In Situ Drug Details: Trastuzumab (Herceptin,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Efgartigimod Alfa + Hyaluronidase (human Recombinant)) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Efgartigimod Alfa + Hyaluronidase (human Recombinant)) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Efgartigimod Alfa +...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Trastuzumab in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trastuzumab in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trastuzumab in Non-Small Cell Lung Cancer Drug Details: Trastuzumab (Herceptin,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lurbinectedin in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lurbinectedin in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lurbinectedin in Colorectal Cancer Drug Details: Lurbinectedin (Zepzelca) is a synthetic...